PE-backed MeriCal appoints new CEO

MeriCal, which is backed by Linden Capital Partners, has named Mark Walsh as CEO and a member of the board of directors. Brian Smith is stepping down as CEO but will remain as an adviser to the management team and the board of directors. MeriCal is a producer of high-quality probiotics and other nutritional supplement products.

PRESS RELEASE

Anaheim, CA (August 20, 2019) – MeriCal, LLC (“MeriCal”) is pleased to announce the appointment of Mark Walsh as CEO and member of the Board of Directors. Mr. Walsh brings over 30 years of experience in the food and nutrition industries, having served in numerous senior executive roles at organizations including Pharmavite, Corr-Jensen, Twinlab, and Mars.

“MeriCal has built an extraordinary business focused on manufacturing high-quality nutritional products, excelling in the fast-growing probiotics segment, and delivering innovative solutions to its customers across all channels. I am honored and excited by the opportunity to contribute to this organization,” Walsh said.

Brian Smith, who has served as CEO since the investment by Linden Capital Partners in 2016, is stepping down from day-to-day duties as CEO but will remain involved as an advisor to the management team and the Board of Directors. Mr. Smith’s accomplishments include leading the acquisition of Global Health Industries and driving significant organic growth over the last three years. The MeriCal management team and Board of Directors are grateful for his leadership and dedication to the company.

“My experience as CEO at MeriCal has been immensely rewarding, and I thank the management team, the Board of Directors, and our dedicated employees in both California and Utah for the privilege of leading MeriCal throughout this three-year period of rapid growth and transformation,” Smith said.

“Mark is an experienced executive with a history of success in the nutritional supplements industry, and we are fortunate to have him join the MeriCal management team and Board of Directors,” added Ernest Waaser, Chairman of MeriCal and Operating Partner at Linden Capital Partners.

About MeriCal, LLC
MeriCal, LLC is a recognized industry leader in the production of high-quality probiotic and other nutritional supplement products. The company provides value-added contract manufacturing and custom bottling and packaging services along with a broad range of laboratory support services to several of the most recognized retailers and nutritional supplement brands in the industry. For more information, please visit www.merical.com.

About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry. Linden’s strategy is based upon three elements: i) healthcare specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit www.lindenllc.com.